Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has completed the acquisition of Organon, a pharmacy business in New Jersey, for $11.75B. Organon supports women’s health and specialty medicines, strengthening Sun Pharma’s product portfolio across healthcare M&A. Sun Pharma acquisitions in the pharmacy sector aim to expand branded and specialty offerings while leveraging Organon’s established commercial capabilities. The strategic acquisition is structured as a merger acquisition and is part of broader healthcare M&A activity, with the deal announced and valued at $11.75B.